Loading stock data…
UBS
$43.69-0.21 (-0.48%)
Market ClosedLast close May 1
UBS Group AG operates as a wealth manager and bank worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
UBS Group AG in the Financial Services sector is trading at $43.69. The stock is currently 11% below its 52-week high of $49.36, remaining 8.9% above its 200-day moving average. Technical signals show neutral RSI of 64 and bullish MACD crossover, explaining why UBS maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 64) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$43.69
Potential Upside
7.9%
Whystock Fair Value$47.16
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Buy
Mean target$48.13+10.2%
Range$42.00 – $58.40
Fundamentals
UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$133.97B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
17.97
Beta
Defensive asset. Lower volatility than the S&P 500.
0.79
Div Yield
Strong income play. Yield provides a meaningful total return floor.
254.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.96%
Volume
Today's trading volume
1.65M
Recent News
How The Investment Story For KGHM Polska Miedz (WSE:KGH) Is Shifting After Recent Analyst Moves
The central fair value estimate for KGHM Polska Miedz has shifted from PLN 283.92 to PLN 306.55, giving you an updated reference point for where analysts now see the shares as fairly valued. This change sits between a set of higher and lower price targets, from upgrades such as the UBS move to more cautious calls such as Citi’s PLN 209 Sell rating, and reflects an active debate over how much upside or downside is already in the price. Read on to see what is driving these opposing views and...
Citi Raises Western Digital Price Target to $500: Is the HDD Bull Case Just Getting Stronger?
Western Digital (NASDAQ:WDC) stock just received its most aggressive price target raise of the cycle. Citi lifted its price target to $500 from $405, maintaining a Buy rating, citing a beat-and-raise quarter and improving visibility into AI-driven hard disk drive (HDD) demand. The move arrives alongside fresh revisions from Barclays and UBS, sharpening the debate ... Citi Raises Western Digital Price Target to $500: Is the HDD Bull Case Just Getting Stronger?
UBS Initiates Coverage of Amneal Pharmaceuticals (AMRX) With a Bullish Outlook
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best drug stocks to buy according to analysts. On April 17, UBS initiated coverage of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) with a Buy rating and set a $19 price target. The firm told investors in a research note that the recent share selloff on the macro environment offers […]
How The Taseko Mines (TSX:TKO) Investment Story Is Evolving As Expectations Tighten
Taseko Mines’ fair value estimate has shifted slightly, moving from about CA$12.61 to roughly CA$12.54 in the latest update. Recent analyst commentary views this small adjustment as more of a refinement than a reset, with debate centering on how much future growth is already reflected in today’s pricing versus the company’s ability to deliver on its plans. As you read on, you will see how this updated fair value fits into the wider narrative and how to keep track of where the story goes...
UBS's $3 Billion Quarter Puts New Buyback Hopes In Focus
UBS's strong first quarter raises expectations for another $3 billion buyback as Swiss capital-rule pressure intensifies.